Immune thrombocytopenia caused by piperacillin/tazobactam

被引：24
|
作者：
Pérez-Vázquez, A
Pastor, JM
Riancho, JA
机构：
[1] Univ Zurich, Swiss Natl Ctr Mycobacteria, Dept Med Microbiol, CH-8006 Zurich, Switzerland
[2] Univ Zurich Hosp, Dept Surg, Zurich, Switzerland
[3] Univ Zurich Hosp, Dept Internal Med, Zurich, Switzerland
来源：
CLINICAL INFECTIOUS DISEASES | 1998年 / 27卷 / 03期
关键词：
D O I：
10.1086/517143
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：650 / 651
页数：2
相关论文
共 50 条
  • [41] Piperacillin/tazobactam-induced sudden severe thrombocytopenia in a patient with a pressure ulcer: a case report
    Roh, Solji
    Hashimoto, Kohei
    Kiriishi, Rina
    Matsubara, Ken
    Isozaki, Yuki
    Tanaka, Hiroaki
    Kuwata, Tomoyuki
    JOURNAL OF WOUND CARE, 2024, 33 : S25 - S30
  • [42] Synergistic effect of polyethylenimine plus piperacillin/tazobactam on clinicalPseudomonas aeruginosa isolates resistant to piperacillin/tazobactam
    Giovanni Bonfiglio
    Annals of Microbiology, 2006, 56 : 345 - 348
  • [43] Cefalexin/piperacillin/tazobactamLack of efficacy and immune thrombocytopenia: case report
    Reactions Weekly, 2021, 1880 (1) : 114 - 114
  • [44] Investigation of the clinical breakpoints of piperacillin-tazobactam against infections caused by Pseudomonas aeruginosa
    Yamagishi, Yuka
    Terada, Michinori
    Ohki, Emiko
    Miura, Yoko
    Umemura, Takumi
    Mikamo, Hiroshige
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2012, 18 (01) : 127 - 129
  • [45] Risk Factors of Nosocomial Infections Caused by Piperacillin-Tazobactam Resistant Pseudomonas Aeruginosa
    Djordjevic, Zorana
    Gajovic, Olgica
    Mijailovic, Zeljko
    Ilic, Aleksandra
    Stolic, Radojica
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2013, 141 (9-10) : 640 - 647
  • [46] Leukocytopenia, Thrombocytopenia and Fever Related to Piperacillin/Tazobactam Treatment – A Retrospective Analysis in 38 Children with Cytic Fibrosis
    P. Reichardt
    W. Handrick
    A. Linke
    R. Schille
    W. Kiess
    Infection, 1999, 27 : 355 - 356
  • [47] Piperacillin/tazobactam-heteroresistant Pseudomonas aeruginosa from urinary infection, successfully treated by piperacillin/tazobactam
    Pournaras, Spyros
    Ikonomidis, Alexandros
    Neou, Evangelia
    Kantzanou, Maria
    Maniatis, Antonios N.
    Tsakris, Athanassios
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (03) : 757 - 758
  • [48] Pharmacodynamic interactions of ciprofloxacin, piperacillin, and piperacillin/tazobactam in healthy volunteers
    Strenkoski-Nix, LC
    Forrest, A
    Schentag, JJ
    Nix, DE
    JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 38 (11): : 1063 - 1071
  • [49] Synergistic effect of polyethylenimine plus piperacillin/tazobactam on clinical Pseudomonas aeruginosa isolates resistant to piperacillin/tazobactam
    Bonfiglio, Giovanni
    ANNALS OF MICROBIOLOGY, 2006, 56 (04) : 345 - 348
  • [50] Reevaluating Piperacillin-Tazobactam Mortality
    Darlow, Christopher A.
    Gerada, Alessandro
    Hope, William
    JAMA INTERNAL MEDICINE, 2024, 184 (10) : 1267 - 1268
12345